C. Isaacs Et Al. , "BOLERO-3: Quality-of-life maintained in patients with metastatic breast cancer treated with everolimus plus trastuzumab plus vinorelbine," CANCER RESEARCH , vol.73, 2013
Isaacs, C. Et Al. 2013. BOLERO-3: Quality-of-life maintained in patients with metastatic breast cancer treated with everolimus plus trastuzumab plus vinorelbine. CANCER RESEARCH , vol.73 .
Isaacs, C., Ozguroglu, M., Jerusalem, G., Xu, B., Lang, I., O'Regan, R., ... White, M.(2013). BOLERO-3: Quality-of-life maintained in patients with metastatic breast cancer treated with everolimus plus trastuzumab plus vinorelbine. CANCER RESEARCH , vol.73.
Isaacs, C. Et Al. "BOLERO-3: Quality-of-life maintained in patients with metastatic breast cancer treated with everolimus plus trastuzumab plus vinorelbine," CANCER RESEARCH , vol.73, 2013
Isaacs, C. Et Al. "BOLERO-3: Quality-of-life maintained in patients with metastatic breast cancer treated with everolimus plus trastuzumab plus vinorelbine." CANCER RESEARCH , vol.73, 2013
Isaacs, C. Et Al. (2013) . "BOLERO-3: Quality-of-life maintained in patients with metastatic breast cancer treated with everolimus plus trastuzumab plus vinorelbine." CANCER RESEARCH , vol.73.
@article{article, author={C. Isaacs Et Al. }, title={BOLERO-3: Quality-of-life maintained in patients with metastatic breast cancer treated with everolimus plus trastuzumab plus vinorelbine}, journal={CANCER RESEARCH}, year=2013}